Home > Medical > Tuberculosis > New developments in TB New developments in TB All sections in Tuberculosis » About Tuberculosis » Different political stances » Drug Resistance » FAQs » Health Tips » HIV/Aids and TB » Living with TB » New Developments » TB News » Quarantine » Real-life Story » Symptoms » TB and other organs » TB in South Africa » Testing » Transmission » Treatment » Who is at risk? TB: 6 million lives saved so far This is the first paper in The Lancet series of tuberculosis. This paper focuses on the prevalence and curing of millions of people. Multidrug-resistant forms of TB The second paper in The Lancet series of tuberculosis. This paper focuses on the affects of multidrug-resistant TB, how they are identified and treated. Go get HIV status tested more often The third piece from The Lancet series of tuberculosis focuses on the epidemic of HIV associated TB. Assess Your risk for COPD » Join HIV Talk » Ask CyberDoc » Assess Do you have asthma? » African health in focus World's Most Famous TB Patients Combining new drugs reduces TB Papers four, five and six in The Lancet series on tuberculosis, looks at the effects of drugs, vaccines, biomarkers and diagnostics of TB. TB can no longer be neglected The eighth and final paper on the Lancet series on tuberculosis, a call to action is made to a wide range of sectors to assist scale-up TB service delivery, research and control. Major TB jab trialled in SA The first new vaccine against tuberculosis in more than 80 years has entered mid-stage trials in South Africa, where the killer disease is rife, scientists say. TB’s secret weapon exposed The germ which causes tuberculosis has a cloaked weapon that weakens the body's defences, according to new research. Strengthen the TB response The seventh paper in the Lancet series on Tuberculosis (TB) shows how health system bottlenecks are impeding global efforts to control tuberculosis. TB: get tested This ancient disease is posing more of a global health emergency than ever – even though it is curable and cost-effective to treat. XDR-TB breakthrough South African scientists announced on Thursday that they have for the first time been able to fully decode the genetic blueprint to drug resistant tuberculosis. load more articles advertisement From our sponsors Hill's Science Plan Canine Mini range What is Diabetic Neuropathy? There are more than 200 different viruses which can cause a cold A clinically proven skin care range is now available
TB: 6 million lives saved so far This is the first paper in The Lancet series of tuberculosis. This paper focuses on the prevalence and curing of millions of people.
Multidrug-resistant forms of TB The second paper in The Lancet series of tuberculosis. This paper focuses on the affects of multidrug-resistant TB, how they are identified and treated.
Go get HIV status tested more often The third piece from The Lancet series of tuberculosis focuses on the epidemic of HIV associated TB.
Combining new drugs reduces TB Papers four, five and six in The Lancet series on tuberculosis, looks at the effects of drugs, vaccines, biomarkers and diagnostics of TB.
TB can no longer be neglected The eighth and final paper on the Lancet series on tuberculosis, a call to action is made to a wide range of sectors to assist scale-up TB service delivery, research and control.
Major TB jab trialled in SA The first new vaccine against tuberculosis in more than 80 years has entered mid-stage trials in South Africa, where the killer disease is rife, scientists say.
TB’s secret weapon exposed The germ which causes tuberculosis has a cloaked weapon that weakens the body's defences, according to new research.
Strengthen the TB response The seventh paper in the Lancet series on Tuberculosis (TB) shows how health system bottlenecks are impeding global efforts to control tuberculosis.
TB: get tested This ancient disease is posing more of a global health emergency than ever – even though it is curable and cost-effective to treat.
XDR-TB breakthrough South African scientists announced on Thursday that they have for the first time been able to fully decode the genetic blueprint to drug resistant tuberculosis.